비침습적 척수 자극술 시장 : 규모, 점유율, 성장률 및 산업 분석, 지역별 동향 및 예측(2026-2034년)

Growth Factors of non-invasive spinal cord stimulation Market

The global non-invasive spinal cord stimulation market was valued at USD 4.2 million in 2025 and is projected to grow from USD 7.9 million in 2026 to USD 66.5 million by 2034, registering an impressive CAGR of 30.4% during the forecast period. North America dominated the global market with a 95.23% market share in 2025, driven by rapid regulatory approvals, increasing adoption of advanced neurorehabilitation technologies, and strong healthcare infrastructure.

Non-invasive spinal cord stimulation (SCS) is an advanced neuromodulation therapy that delivers electrical stimulation through electrodes placed on the skin over the spinal cord. Unlike implantable systems, these devices eliminate the need for surgery while supporting rehabilitation for patients with spinal cord injuries and neurological disorders. Rising incidences of spinal cord injuries, increasing preference for non-invasive therapies, and growing investments in rehabilitation technologies are accelerating market expansion worldwide. According to the World Health Organization (WHO), nearly 15 million people worldwide are living with spinal cord injuries, creating significant demand for innovative rehabilitation solutions.

Market Trends

One of the major trends shaping the non-invasive spinal cord stimulation market is the shift from implantable neuromodulation systems toward external stimulation technologies. Transcutaneous spinal cord stimulation (tSCS) devices are increasingly being adopted in rehabilitation hospitals, specialty clinics, and home-based therapy settings because they offer effective neurological recovery without invasive surgery.

Clinical evidence continues to strengthen market confidence. A 2024 Nature Medicine study demonstrated that external cervical spinal cord stimulation combined with rehabilitation significantly improved hand and arm function among patients with chronic tetraplegia. Similar positive outcomes from the Up-LIFT clinical study have accelerated commercialization and adoption of these innovative therapies.

Market Drivers

The increasing burden of spinal cord injuries remains the primary driver of market growth. Growing demand for treatments that improve mobility, upper limb function, neurological recovery, and quality of life is encouraging healthcare providers to adopt non-invasive spinal cord stimulation devices.

According to the Christopher & Dana Reeve Foundation, the annual incidence of spinal cord injury in the U.S. reached approximately 54 cases per one million people in 2026. In addition, expanding rehabilitation infrastructure, increasing product approvals, and continuous investment in research and development by leading manufacturers are supporting rapid market expansion.

Market Restraints

Despite strong growth potential, limited reimbursement policies continue to restrict market adoption. Many healthcare systems have yet to establish standardized reimbursement pathways for non-invasive spinal cord stimulation therapies, increasing the financial burden on hospitals, rehabilitation centers, and patients.

The total treatment cost includes the stimulation device, rehabilitation sessions, clinician training, follow-up care, and therapy management, making affordability a major concern in several countries. These reimbursement limitations continue to slow adoption, particularly in emerging healthcare markets.

Market Opportunities

Rapid expansion of healthcare infrastructure across developing countries presents significant opportunities for industry participants. Countries such as India, Brazil, and several emerging economies are investing heavily in hospitals, rehabilitation centers, and neurological care facilities.

Increasing awareness of non-invasive rehabilitation technologies, combined with improving healthcare access and rising demand for advanced spinal cord injury treatments, is expected to create favorable growth opportunities throughout the forecast period.

Market Segmentation

Based on product type, the stimulation systems segment dominated the market in 2025 owing to increasing demand for advanced non-invasive spinal cord stimulation devices. The accessories segment is projected to register the fastest growth with a 35.9% CAGR during the forecast period.

By technology, transcutaneous electrical spinal cord stimulation (tSCS) accounted for the largest market share of 97.9% in 2025, supported by strong clinical validation and increasing regulatory approvals. The transspinal magnetic stimulation segment is anticipated to witness the highest growth during the forecast period.

Based on stimulation site, the cervical spine segment dominated with an 85.9% market share in 2025, driven by the high prevalence of cervical spinal cord injuries and increasing use of rehabilitation therapies for upper-limb functional recovery. The thoracic spine segment is expected to experience significant growth through 2034.

By application, spinal cord injury rehabilitation accounted for the largest share of 48.9% in 2025, reflecting the growing clinical focus on restoring movement and neurological function. The autonomic dysfunction management segment is expected to grow rapidly over the forecast period.

Based on end user, hospitals remained the leading segment in 2025 and are expected to account for 82.9% of the market in 2026, supported by expanding rehabilitation services and increasing hospital infrastructure. Specialty clinics are also projected to witness substantial growth.

Regional Outlook

North America dominated the global market with a valuation of USD 4.0 million in 2025. Strong healthcare expenditure, rising prevalence of spinal cord injuries, continuous FDA approvals, and rapid commercialization of advanced neurostimulation technologies continue to support regional leadership. The U.S. market is estimated to reach approximately USD 7.2 million in 2026, representing nearly 90.8% of global revenue.

Europe is expected to record the second-highest regional growth, reaching approximately USD 0.6 million in 2026, supported by increasing neurological rehabilitation programs and growing adoption of non-invasive treatment technologies.

Asia Pacific remains an emerging market with commercialization expected to accelerate after 2027 as healthcare infrastructure expands across China, India, and Japan. Latin America and the Middle East & Africa are also projected to witness gradual growth due to improving rehabilitation facilities and increasing healthcare investments.

Competitive Landscape

The market remains highly competitive with companies focusing on regulatory approvals, product innovation, clinical research, and commercialization strategies. Strong research collaborations and continuous product development are strengthening competitive positioning.

Major companies operating in the market include ONWARD Medical, ANEUVO, SpineX Inc., COSIMA, University of Washington, Kessler Foundation, University of Louisville, and University of Miami.

Key Industry Developments

Several important developments have accelerated market growth. In April 2026, ANEUVO received FDA approval for its ExaStim Stimulation System, strengthening its commercial presence. In November 2025, ONWARD Medical secured FDA approval for home use of its ARC-EX System in the U.S. SpineX Inc. also received regulatory approval in India for its xStep device during October 2025, expanding its international footprint. Earlier approvals, including FDA De Novo authorization and CE Mark certification for ONWARD Medical's ARC-EX System during 2024 and 2025, have significantly accelerated global commercialization.

Conclusion

The global non-invasive spinal cord stimulation market is expected to witness exceptional growth between 2025 and 2034, driven by increasing spinal cord injury prevalence, rapid technological advancements, favorable regulatory approvals, and expanding rehabilitation infrastructure. The growing preference for non-invasive neuromodulation therapies, coupled with continued investment in clinical research and innovative stimulation technologies, is expected to create substantial growth opportunities for manufacturers and healthcare providers worldwide throughout the forecast period.

Segmentation By Product Type, Technology, Stimulation Site, Application, End User, and Region

By Product Type * Stimulation Systems

• Accessories

By Technology * Transcutaneous Electrical Spinal Cord Stimulation (tSCS)

• Transspinal Magnetic Stimulation
• Others

By Stimulation Site * Cervical Spine

• Thoracic Spine
• Lumbosacral Spine

By Application * Spinal Cord Injury Rehabilitation

• Stroke & Neurological Motor Rehabilitation
• Autonomic Dysfunction Management
• Others

By End User * Hospitals

• Specialty Clinics
• Homecare Settings
• Others

By Region * North America (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country)

• U.S. (By Product Type)
• Canada (By Product Type)
• Europe (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country/Sub-region)
  • U.K. (By Product Type)
  • Germany (By Product Type)
  • France (By Product Type)
  • Italy (By Product Type)
  • Spain (By Product Type)
  • Scandinavia (By Product Type)
  • Rest of Europe (By Product Type)
• Asia Pacific (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country/Sub-region)
  • China (By Product Type)
  • Japan (By Product Type)
  • India (By Product Type)
  • Australia (By Product Type)
  • Southeast Asia (By Product Type)
  • Rest of Asia Pacific (By Product Type)
• Latin America (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country/Sub-region)
  • Brazil (By Product Type)
  • Mexico (By Product Type)
  • Rest of Latin America (By Product Type)
• Middle East & Africa (By Product Type, By Technology, By Stimulation Site, By Application, By End User, and by Country/Sub-region)
  • GCC (By Product Type)
  • South Africa (By Product Type)
  • Rest of the Middle East & Africa (By Product Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Challenges
• 3.5. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Disorders, Key Countries/Region, 2025
• 4.2. Pipeline Analysis, Key Players
• 4.3. New Product Launches, Key Players
• 4.4. Key Industry Developments - Mergers, Acquisitions & Partnerships

5. Global Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Stimulation Systems
  • 5.1.2. Accessories
• 5.2. Market Analysis, Insights and Forecast - By Technology
  • 5.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
  • 5.2.2. Transspinal Magnetic Stimulation
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Stimulation Site
  • 5.3.1. Cervical Spine
  • 5.3.2. Thoracic Spine
  • 5.3.3. Lumbosacral Spine
• 5.4. Market Analysis, Insights and Forecast - By Application
  • 5.4.1. Spinal Cord Injury Rehabilitation
  • 5.4.2. Stroke & Neurological Motor Rehabilitation
  • 5.4.3. Autonomic Dysfunction Management
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By End User
  • 5.5.1. Hospitals
  • 5.5.2. Specialty Clinics
  • 5.5.3. Homecare Settings
  • 5.5.4. Others
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Stimulation Systems
  • 6.1.2. Accessories
• 6.2. Market Analysis, Insights and Forecast - By Technology
  • 6.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
  • 6.2.2. Transspinal Magnetic Stimulation
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Stimulation Site
  • 6.3.1. Cervical Spine
  • 6.3.2. Thoracic Spine
  • 6.3.3. Lumbosacral Spine
• 6.4. Market Analysis, Insights and Forecast - By Application
  • 6.4.1. Spinal Cord Injury Rehabilitation
  • 6.4.2. Stroke & Neurological Motor Rehabilitation
  • 6.4.3. Autonomic Dysfunction Management
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By End User
  • 6.5.1. Hospitals
  • 6.5.2. Specialty Clinics
  • 6.5.3. Homecare Settings
  • 6.5.4. Others
• 6.6. Market Analysis, Insights and Forecast - By Country
  • 6.6.1. U.S.
    • 6.6.1.1. By Product Type
  • 6.6.2. Canada
    • 6.6.2.1. By Product Type

7. Europe Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Stimulation Systems
  • 7.1.2. Accessories
• 7.2. Market Analysis, Insights and Forecast - By Technology
  • 7.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
  • 7.2.2. Transspinal Magnetic Stimulation
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Stimulation Site
  • 7.3.1. Cervical Spine
  • 7.3.2. Thoracic Spine
  • 7.3.3. Lumbosacral Spine
• 7.4. Market Analysis, Insights and Forecast - By Application
  • 7.4.1. Spinal Cord Injury Rehabilitation
  • 7.4.2. Stroke & Neurological Motor Rehabilitation
  • 7.4.3. Autonomic Dysfunction Management
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By End User
  • 7.5.1. Hospitals
  • 7.5.2. Specialty Clinics
  • 7.5.3. Homecare Settings
  • 7.5.4. Others
• 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.6.1. U.K.
    • 7.6.1.1. By Product Type
  • 7.6.2. Germany
    • 7.6.2.1. By Product Type
  • 7.6.3. France
    • 7.6.3.1. By Product Type
  • 7.6.4. Spain
    • 7.6.4.1. By Product Type
  • 7.6.5. Italy
    • 7.6.5.1. By Product Type
  • 7.6.6. Scandinavia
    • 7.6.6.1. By Product Type
  • 7.6.7. Rest of Europe
    • 7.6.7.1. By Product Type

8. Asia Pacific Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Stimulation Systems
  • 8.1.2. Accessories
• 8.2. Market Analysis, Insights and Forecast - By Technology
  • 8.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
  • 8.2.2. Transspinal Magnetic Stimulation
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Stimulation Site
  • 8.3.1. Cervical Spine
  • 8.3.2. Thoracic Spine
  • 8.3.3. Lumbosacral Spine
• 8.4. Market Analysis, Insights and Forecast - By Application
  • 8.4.1. Spinal Cord Injury Rehabilitation
  • 8.4.2. Stroke & Neurological Motor Rehabilitation
  • 8.4.3. Autonomic Dysfunction Management
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By End User
  • 8.5.1. Hospitals
  • 8.5.2. Specialty Clinics
  • 8.5.3. Homecare Settings
  • 8.5.4. Others
• 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.6.1. Japan
    • 8.6.1.1. By Product Type
  • 8.6.2. Australia
    • 8.6.2.1. By Product Type
  • 8.6.3. China
    • 8.6.3.1. By Product Type
  • 8.6.4. India
    • 8.6.4.1. By Product Type
  • 8.6.5. Southeast Asia
    • 8.6.5.1. By Product Type
  • 8.6.6. Rest of Asia Pacific
    • 8.6.6.1. By Product Type

9. Latin America Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Stimulation Systems
  • 9.1.2. Accessories
• 9.2. Market Analysis, Insights and Forecast - By Technology
  • 9.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
  • 9.2.2. Transspinal Magnetic Stimulation
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Stimulation Site
  • 9.3.1. Cervical Spine
  • 9.3.2. Thoracic Spine
  • 9.3.3. Lumbosacral Spine
• 9.4. Market Analysis, Insights and Forecast - By Application
  • 9.4.1. Spinal Cord Injury Rehabilitation
  • 9.4.2. Stroke & Neurological Motor Rehabilitation
  • 9.4.3. Autonomic Dysfunction Management
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By End User
  • 9.5.1. Hospitals
  • 9.5.2. Specialty Clinics
  • 9.5.3. Homecare Settings
  • 9.5.4. Others
• 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.6.1. Brazil
    • 9.6.1.1. By Product Type
  • 9.6.2. Mexico
    • 9.6.2.1. By Product Type
  • 9.6.3. Rest of Latin America
    • 9.6.3.1. By Product Type

10. Middle East & Africa Non-invasive Spinal Cord Stimulation Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Stimulation Systems
  • 10.1.2. Accessories
• 10.2. Market Analysis, Insights and Forecast - By Technology
  • 10.2.1. Transcutaneous Electrical Spinal Cord Stimulation (tSCS)
  • 10.2.2. Transspinal Magnetic Stimulation
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Stimulation Site
  • 10.3.1. Cervical Spine
  • 10.3.2. Thoracic Spine
  • 10.3.3. Lumbosacral Spine
• 10.4. Market Analysis, Insights and Forecast - By Application
  • 10.4.1. Spinal Cord Injury Rehabilitation
  • 10.4.2. Stroke & Neurological Motor Rehabilitation
  • 10.4.3. Autonomic Dysfunction Management
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By End User
  • 10.5.1. Hospitals
  • 10.5.2. Specialty Clinics
  • 10.5.3. Homecare Settings
  • 10.5.4. Others
• 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.6.1. GCC
    • 10.6.1.1. By Product Type
  • 10.6.2. South Africa
    • 10.6.2.1. By Product Type
  • 10.6.3. Rest of Middle East & Africa
    • 10.6.3.1. By Product Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. ONWARD Medical
  • 11.2.2. ANEUVO
  • 11.2.3. SpineX Inc.
  • 11.2.4. COSIMA
  • 11.2.5. University of Washington
  • 11.2.6. Kessler Foundation
  • 11.2.7. University of Louisville
  • 11.2.8. University of Miami